Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Gajewski

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Journal of the American Chemical Society|November 1, 2001
Is the tert-butyl chloride solvolysis the most misunderstood reaction in organic chemistry? Evidence against nucleophilic solvent participation in the tert-butyl chloride transition state and for increased hydrogen bond donation to the 1-adamantyl chloride solvolysis transition stateJ J Gajewski
Current Opinion in Oncology|March 1, 1996
Bone marrow transplantation from unrelated donorsJ Gajewski, R Champlin
Clinical Biomechanics (Bristol, Avon)|August 7, 2013
Knee angle as a determinant of lower leg tremorJ T Viitasalo, J Gajewski
JAMA|April 17, 1981
Mortality in an insured population with atrial fibrillationJ Gajewski, R B Singer
BMC Medical Research Methodology|July 22, 2020
Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trialsXiaqing Huang, Byron J Gajewski
Organic Letters|August 31, 2000
Equilibrium constants between boron trifluoride etherate and carbonyl compounds in chloroform solutionJ J Gajewski, P Ngernmeesri
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2012
Identifying individual changes in performance with composite quality indicators while accounting for regression to the meanByron J Gajewski, Nancy Dunton
Statistics in Biopharmaceutical Research|March 6, 2023
Comparative Effectiveness Research using Bayesian Adaptive Designs for Rare Diseases: Response Adaptive Randomization Reusing ParticipantsFengming Tang, Byron J Gajewski
JAMA|February 10, 1984
Insurance premium reductions. A motivating factor in long-term hypertensive treatmentM Moser, J Rafter, J Gajewski
Statistics in Medicine|December 14, 2005
Bayesian sample size calculations in phase II clinical trials using a mixture of informative priorsByron J Gajewski, Matthew S Mayo
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Journal of the American Chemical Society|November 1, 2001
Is the tert-butyl chloride solvolysis the most misunderstood reaction in organic chemistry? Evidence against nucleophilic solvent participation in the tert-butyl chloride transition state and for increased hydrogen bond donation to the 1-adamantyl chloride solvolysis transition stateJ J Gajewski
Current Opinion in Oncology|March 1, 1996
Bone marrow transplantation from unrelated donorsJ Gajewski, R Champlin
Clinical Biomechanics (Bristol, Avon)|August 7, 2013
Knee angle as a determinant of lower leg tremorJ T Viitasalo, J Gajewski
JAMA|April 17, 1981
Mortality in an insured population with atrial fibrillationJ Gajewski, R B Singer
BMC Medical Research Methodology|July 22, 2020
Comparison of hierarchical EMAX and NDLM models in dose-response for early phase clinical trialsXiaqing Huang, Byron J Gajewski
Organic Letters|August 31, 2000
Equilibrium constants between boron trifluoride etherate and carbonyl compounds in chloroform solutionJ J Gajewski, P Ngernmeesri
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 5, 2012
Identifying individual changes in performance with composite quality indicators while accounting for regression to the meanByron J Gajewski, Nancy Dunton
Statistics in Biopharmaceutical Research|March 6, 2023
Comparative Effectiveness Research using Bayesian Adaptive Designs for Rare Diseases: Response Adaptive Randomization Reusing ParticipantsFengming Tang, Byron J Gajewski
JAMA|February 10, 1984
Insurance premium reductions. A motivating factor in long-term hypertensive treatmentM Moser, J Rafter, J Gajewski
Statistics in Medicine|December 14, 2005
Bayesian sample size calculations in phase II clinical trials using a mixture of informative priorsByron J Gajewski, Matthew S Mayo
Pageof 25